These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6401999)

  • 41. Acute arterial thrombosis in rabbits: reduced platelet accumulation after treatment with thromboxane synthetase inhibitor dazoxiben hydrochloride, (UK-37, 248-01).
    Randall MJ; Wilding RI
    Thromb Res; 1982 Dec; 28(5):607-16. PubMed ID: 6897751
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Platelet behaviour in normal pregnancy, pregnancy complicated by essential hypertension and pregnancy-induced hypertension.
    Morrison R; Crawford J; MacPherson M; Heptinstall S
    Thromb Haemost; 1985 Oct; 54(3):607-11. PubMed ID: 3937260
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low dose aspirin, platelet function and prostaglandin synthesis: influence of epinephrine and alpha adrenergic blockade.
    Rao GH; Reddy RK; White JG
    Prostaglandins Med; 1981 May; 6(5):485-94. PubMed ID: 6115432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of diltiazem and low-dose aspirin on platelet aggregation and ATP release induced by paired agonists.
    Zucker ML; Budd SE; Dollar LE; Chernoff SB; Altman R
    Thromb Haemost; 1993 Aug; 70(2):332-5. PubMed ID: 8236144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade.
    Golino P; Ambrosio G; Gresele P; Pascucci I; Ragni M; Russolillo E; Leproux GB; Chiariello M
    J Pharmacol Exp Ther; 1993 Aug; 266(2):511-7. PubMed ID: 8355187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of oral diltiazem on platelet function: alone and in combination with "low dose" aspirin.
    Ring ME; Corrigan JJ; Fenster PE
    Thromb Res; 1986 Nov; 44(3):391-400. PubMed ID: 3798404
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of a selective thromboxane synthetase inhibitor, dazoxiben, and of acetylsalicylic acid on myocardial ischemia in patients with coronary artery disease.
    Thaulow E; Dale J; Myhre E
    Am J Cardiol; 1984 May; 53(9):1255-8. PubMed ID: 6538740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the effects of selective inhibition of thromboxane synthase with those of inhibition of the cyclooxygenase enzyme in man.
    Oates JA; Brash A; Fitzgerald G
    Trans Am Clin Climatol Assoc; 1984; 95():157-62. PubMed ID: 6433527
    [No Abstract]   [Full Text] [Related]  

  • 49. Increased whole blood platelet aggregation in normal pregnancy can be prevented in vitro by aspirin and dazmegrel (UK38485).
    Norris LA; Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1992 Mar; 99(3):253-7. PubMed ID: 1606123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of the thromboxane synthetase inhibitor Dazoxiben (UK 37-248) on the metabolism of antipyrine in patients with enhanced platelet aggregation.
    Staiger C; Walter E; Wang NS; Schuhmacher E; de Vries J; Weber E
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):250-3. PubMed ID: 6540249
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prolongation of platelet survival in hypercholesterolaemic rabbits by CGS 12970 (3-methyl-2-(3-pyridyl)-1 indoleoctanoic acid) and dazoxiben.
    Butler KD; Butler PA; Shand RA; Ambler J; Wallis RB
    Thromb Res; 1987 Mar; 45(6):751-61. PubMed ID: 3109067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of single oral dose of aspirin on human platelet functions and plasma plasminogen activator inhibitor-1.
    Mousa SA; Forsythe MS; Bozarth JM; Reilly TM
    Cardiology; 1993; 83(5-6):367-73. PubMed ID: 8111770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of camonagrel, a selective inhibitor of platelet thromboxane synthase, on the platelet-subendothelium interaction.
    Villalobos MA; De La Cruz JP; Escalante R; Arrebola MM; Guerrero A; Sánchez de la Cuesta F
    Pharmacology; 2003 Sep; 69(1):44-50. PubMed ID: 12886030
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of arachidonic acid on the aggregability of human platelet rich plasma.
    Dahl ML; Puustinen T; Uotila P
    Prostaglandins Leukot Med; 1982 Feb; 8(2):133-9. PubMed ID: 6804991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition.
    Hanson SR; Harker LA; Bjornsson TD
    J Clin Invest; 1985 May; 75(5):1591-9. PubMed ID: 3923041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potentiation of ADP-induced aggregation in human platelet-rich plasma by 5-hydroxytryptamine and adrenaline.
    Vanags DM; Rodgers SE; Duncan EM; Lloyd JV; Bochner F
    Br J Pharmacol; 1992 Aug; 106(4):917-23. PubMed ID: 1393289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of thromboxane synthetase inhibitors on platelet function: enhancement by inhibition of phosphodiesterase.
    Smith JB
    Thromb Res; 1982 Nov; 28(4):477-85. PubMed ID: 6891843
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of heparin on platelet aggregation and release and thromboxane A2 production.
    Mohammad SF; Anderson WH; Smith JB; Chuang HY; Mason RG
    Am J Pathol; 1981 Aug; 104(2):132-41. PubMed ID: 7258300
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression.
    Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL
    Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
    Gorman RR
    Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.